Bridgebio Pharma Inc
BBIO
$43.99+1.16 (+2.71%)
Jul 6, 2025, 4:00 PM
Financials
| 52Week High | 45.48 | 52Week Low | 21.72 |
| Beta | 1.22 | Current Ratio Annual | 4.67 |
| Current Ratio Quarterly | 4.57 | Gross Margin TTM | 95.35 |
| Market Cap | 8.35B | Net Profit Margin TTM | -524.25 |
| Operating Margin TTM | -424.22 | Price To Book | 144.26 |
| Price To Sales TTM | 65.56 | Quick Ratio Annual | 4.44 |
| Quick Ratio Quarterly | 4.31 | Return On Assets TTM | -81.95 |
| Return On Equity TTM | -206.74 | Return On Investment TTM | -65.34 |
| Revenue Growth3Y | 47.10 | Revenue Growth5Y | 40.48 |
| Revenue Growth Quarterly Yoy | -44.76 | Revenue Growth TTMYoy | -41.71 |
| Revenue Per Share TTM | 0.67 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 307 | 69 | 33 | 117 | 84 | 29 | 200.02M | $6.81B |
| Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
| Change | 307(100%) | 69(100%) | 33(100%) | 117(100%) | 84(100%) | 29(100%) | 200.02M(100%) | $6.81B(100%) |